Home > About Us > CNIO News, Year 2015

CNIO News, Year 2015

The CNIO celebrates the work and dedication of its young scientists

Madrid, 7 December, 2015

Last Thursday, December 3, the Spanish National Cancer Research Centre (CNIO) held the fifth edition of Lab Day. The purpose of this event, organised by the Dean’s Office for Academic Affairs in collaboration with the Centre’s pre-doctoral (CNIOSA) and post-doctoral (CNIO-PDA) researchers, is to acknowledge the dedication and good work of its young investigators and to provide opportunities for interaction between research groups.During Lab Day, CNIO students and young researchers presented...

Read more...
Logo CNIO

FEI awards the CNIO's innovation strategy

Madrid, 27 November, 2015

The Foro de Empresas Innovadoras (FEI) presented yesterday their 3rd annual Innovation Recognition Awards, to honour Spanish institutions, companies and individuals for their Commitment to Innovation. The prize for the “2015 Institution Supporting Innovation” category went to the Spanish National Cancer Research Centre (CNIO), for the promotion and development of innovative technologies within the oncology field that benefit the Spanish National Health System and the National System of Science...

Read more...

Óscar Fernández-Capetillo, 'Carmen y Severo Ochoa' Award 2015

Madrid, 11 November, 2015

The Judging panel of the Carmen y Severo Ochoa Research Award in Molecular Biology has unanimously granted this prestigious prize to the biochemist, Óscar Fernández- Capetillo, Head of the Genomic Instability Group at the Spanish National Cancer Research Centre (CNIO). The award acknowledges the researcher's outstanding discoveries in the field of replicative stress, i.e. the damage to the DNA generated in cells during their replication, a phenomenon inherent to life that is closely related to...

Read more...
Logo CNIO

The CNIO renews the ‘Severo Ochoa’ Award of Excellence

Madrid, 28 October, 2015

The Secretariat of State for Research, Development and Innovation has announced the renewal of the ‘Severo Ochoa’ Award of Excellence of the Spanish National Cancer Research Centre (CNIO). This distinction is granted to the highest scores given by the evaluators, who have positively evaluated our Centre’s research and strategic plan for 2016L2019.According to the evaluators, the CNIO is one of the leading research institutions in the field of oncology. In particular, they highlighted the...

Read more...
Logo CNIO

Spain joins the European Consortium ELIXIR for managing and analysing biological data

Madrid, 23 October, 2015

At their meeting today in Hinxton (UK), the ELIXIR Board unanimously accepted Spain and France as full members of ELIXIR, the largest infrastructure of life science data in Europe. ELIXIR’s aim is to manage, exploit, and distribute the massive amounts of information generated currently by biomedical research. Entering this partnership will allow Spain to strengthen its ties with Europe and to lead large-scale projects in biomedicine, such as those related to human genomic diseases.Until now,...

Read more...

African women scientists do research in Spain

Madrid, 15 October, 2015

In the coming days, the African women scientists selected in MxA’s project "Science by Women" will begin to arrive in Spain. The initiative aims to promote and support the work being carried out by women in Africa in significant areas such as energy, climate change, healthcare, agriculture and food safety and security.A total of nine women scientists from eight countries will benefit from the research programmes lasting six months to be carried out in the five Spanish centres of excellence that...

Read more...
Logo CNIO

David Olmos wins 1st Prize for Young Researchers awarded by the AstraZeneca Foundation

Madrid, 30 September, 2015

At a ceremony held on September 24 on the premises of the Spanish National Cancer Research Centre (CNIO), David Olmos — Head of the Prostate Cancer Clinical Research Unit and of the Associated Clinical Unit CNIO-IBIMA of the Virgen de la Victoria and Regional Malaga University Teaching Hospitals — was awarded 1st Prize for Young Researchers in the oncology field by the AstraZeneca Foundation. The purpose of these awards, which are endorsed by the Institute of Health Carlos III, is to recognise...

Read more...
Logo CNIO

The CNIO gathers world's leading experts on metastasis in Madrid

Madrid, 25 September, 2015

One hundred thousand people die of cancer in Spain every year, and 90% of those cases are due to metastasis; the process by which a tumour invades healthy organs or tissue. It can only be detected once it has begun and there are no effective treatments to combat it; consequently, the chances that cancer patients with metastasis have of surviving are significantly reduced. However, in spite of its significance, research on the metastatic process − which could ultimately lead to a cure or...

Read more...
Logo CNIO

The CNIO welcomes 200 visitors to the big European science night

Madrid, 21 September, 2015

The European Researchers’ Night, which will be celebrating its 10th anniversary on September 25, is a big annual party promoted by the European Commission, in which scientists from hundreds of organisations across the continent bring their fascinating work closer to people through talks, interactive scientific demonstrations and guided tours of scientific laboratories and workshops. This year, like every year, the Spanish National Cancer Research Centre (CNIO) will be participating in the...

Read more...
Logo CNIO

The CNIO will lead a melanoma multidisciplinary consortium funded by the AECC

Madrid, 18 September, 2015

In a ceremony that will be held in Burgos on September 23, the Scientific Foundation of the Spanish Cancer Association (AECC) will award a grant of 1.2 million euros to the Spanish National Cancer Research Center (CNIO), to promote a multidisciplinary large-scale project, the aim of which is to take a step forward in the diagnosis and treatment of melanoma. In addition, Cristina Montero from the CNIO Hereditary Endocrine Cancer Group, headed by Mercedes Robledo, will receive a grant to explore...

Read more...

The CNIO and the Jesús Serra Foundation have launched a new edition of their ‘Visiting Researchers’ programme

Madrid, 27 July, 2015

On Friday, 24 July, the Jesus Serra Foundation and the Spanish National Cancer Research Centre (CNIO) introduced the scientists participating in this new edition of the Visiting Researcher Programme at the CNIO headquarters. This programme has been designed to enable reputed scientists from international centres to come and work in Spain.This year, the following internationally renowned scientists have been invited: Marcin Nowtony, head of the laboratory of the International Institute of...

Read more...
Logo CNIO

Medialab-Prado checks out CNIO’s ‘big data’

Madrid, 3 July, 2015

Medialab-Prado, the cultural centre of the Arts, Sport and Tourism Office of the Madrid City Council, has invited the Spanish National Cancer Research Centre (CNIO) to join its Ojo al Data project. Since March, this project has been dedicated to studying the big data phenomenon, i.e. the exponential increase in the volume of information generated by scientific, economic, social and cultural processes. On July 2nd, the CNIO responded to the invitation by opening the doors of its Bioinformatics...

Read more...

College students choose CNIO's science over summer vacation

Madrid, 24 June, 2015

Once again, college students from around the world have chosen to spend part of their summer sharing a workbench with scientists from the Spanish National Cancer Research Centre (CNIO). All of them are in their last year of a biomedical science degree and will be travelling from Spain, the U.S., India and Peru, to experience first-hand — working alongside top-notch researchers — what their future career in science would be like.On this occasion, from among nearly 400 applicants, nine...

Read more...
Logo CNIO

The CNIO receives €7 million from European funds for cancer research

Madrid, 22 June, 2015

Researchers at the Spanish National Cancer Research Centre (CNIO), Manuel Hidalgo, Director of the Clinical Research Programme, and Manuel Serrano, Director of the Molecular Oncology Programme, have both been awarded Advanced Grants by the European Research Council (ERC). Each of them will receive 2.5 million euros to address three of the major challenges in European biomedicine, namely cancer research, personalised medicine and the study of ageing, and to advance the frontiers of knowledge...

Read more...

The CNIO launches a video to promote citizen participation in cancer research

Madrid, 17 June, 2015

In the words of one of the ‘CNIO Friends’ involved in the video released today by the Centre, to attract greater support for research and to share the advances made that are changing the course of this illness: the Spanish National Cancer Research Centre (CNIO) is one of the main cancer research centres in the world, and it is in Madrid, only a short distance from the Bernabeu Stadium, in the northern section of the Paseo de la Castellana, one of the main streets in the city.Recent progress in...

Read more...
Logo CNIO

ELIXIR accelerates with major Horizon 2020 funding

Madrid, 12 June, 2015

ELIXIR has been awarded €19 million from the EU to accelerate the implementation of Europe’s life-science data infrastructure over the next four years. From September 2015, ‘ELIXIR-EXCELERATE’ will facilitate the integration of Europe’s bioinformatics resources, supporting all sectors of life-science R&D. It will deliver excellence to ELIXIR’s users by fast-tracking the development and deployment of essential data services.EXCELERATE funding will help ELIXIR coordinate and extend national...

Read more...

Ten consecutive marathons to support cancer research at the CNIO

Madrid, 31 March, 2015

Marcos Argumosa (1979) from Cantabria, faces the challenge of running ten consecutive marathons, 420 km in ten consecutive days, to support ‘CNIO Friends’, an initiative recently launched by the Spanish National Cancer Research Centre (CNIO) aimed at raising funds for cancer research. Between the 17th and 25th of April, this sportsman will cover the distance between Reinosa in Cantabria and the CNIO headquarters, a route that runs through the Castilian provinces of Palencia, Valladolid and...

Read more...
Logo CNIO

The CNIO reviews the new trends in cancer treatment at an international conference

Madrid, 18 March, 2015

Since the first CNIO Frontiers Meeting on anticancer drug development, held in 2010 (‘Cancer Pharmacogenetics: Personalising Medicine’), significant progress has been made on the subject, confirming that research aimed at the enhanced care of cancer patients is taking the right direction. With the aim of updating the latest developments in this field, the Spanish National Cancer Research Centre (CNIO) has announced its second edition (‘New Trends in Anticancer Drug Development’), which will be...

Read more...

CNIO recruits Manuel Valiente, a brain metastasis expert

Madrid, 12 March, 2015

Manuel Valiente, an expert in brain metastasis —a process by which cancer cells spread to the brain from other parts of the body—, will start a new research group at the Spanish National Cancer Research Centre (CNIO). After working for five years at the Memorial Sloan-Kettering Cancer Center in New York with one of the world leaders in metastasis research, Joan Massagué, Valiente has returned to Madrid to start “a very interesting project from a clinical perspective, because metastasis is...

Read more...

The CNIO broadens its research programme and hires Héctor Peinado to study metastasis

Madrid, 20 January, 2015

The Spanish National Cancer Research Centre (CNIO)’s Molecular Oncology Programme has broadened its lines of research and brought metastasis specialist Héctor Peinado on board. After seven years of work at Cornell University in New York (USA), Peinado returns to Spain and moves his research to the CNIO, where he will study the micro-environment surrounding tumours and its role in the development of metastasis, which causes 90% of cancer deaths.“Until a few years ago, the tumour...

Read more...

Manuel Serrano joins the Royal Academy of Medicine as a Corresponding Member

Madrid, 16 January, 2015

Manuel Serrano, Director of the Molecular Oncology Programme at the Spanish National Cancer Research Centre (CNIO), has been awarded with the Royal Academy of Medicine (RAMN) 2014 Award, becoming a Corresponding Member of the institution.His designation was announced during the opening ceremony of the academic year at the RAMN. Professor Joaquín Poch, the President of the Academy, recognised Manuel Serrano as one of the most important scientists in Spain.Serrano has attained international...

Read more...